BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Arthritis
,
Embryo
,
Personalized medicine
,
Tamoxifen
,
rs7903146
,
MYC
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Lymphocyte function associated antigen-1
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for Lymphocyte function associated antigen-1
Explore Curated Studies Results
Literature
Most Relevant Literature
Structural assessment of SARS-CoV2 accessory protein ORF7a predicts LFA-1 and Mac-1 binding potentia…
LFA-1 knockout inhibited the tumor growth and is correlated with treg cells.
LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) distinctly regulate neutrophil extravasation through hotsp…
LFA-1 Activation in T-Cell Migration and Immunological Synapse Formation.
Allosteric targeting resolves limitations of earlier LFA-1 directed modalities.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
C-X-C Chemokine Receptor 4 in Chronic Lymphocytic Leukemia
Sunitinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lym…
Duvelisib for Ibrutinib-Resistant Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Study of Peptide Vaccination With Tumor Associated Antigens Mixed With Montanide in Patients With CN…
Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Ly…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ